Resistance Plus Aerobic Training Using Different Weekly Frequencies And Hypertension (RADAH)
Hypertension, Cardiovascular Risk Factor, Cardiovascular Diseases
About this trial
This is an interventional treatment trial for Hypertension focused on measuring Aging, Ambulatory Blood Pressure Monitoring, Concurrent Training, Dose-response
Eligibility Criteria
Inclusion Criteria:
Office blood pressure between 130-179 and 80-110 mmHg for systolic and diastolic blood pressure, respectively or taking at least one antihypertensive medication
Not engaged in structured exercise programs (3 or more times per week) in the last 3 months before the study
Exclusion Criteria:
Physical and muscular injuries that limit to accomplishment of the different training proposed in the study
Underlying cardiovascular disease in the last 24 months such as acute myocardial infarction, angina, stroke or heart failure
Health conditions that limit physical exercise perform, such as lung disease, valvar heart disease, renal failure
Diseases that reduce life expectancy
BMI > 39.9 kg/m²
Diabetic proliferative retinopathy
Sites / Locations
- Hospital de Clínicas de Porto AlegreRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Combined Training 4 times per week (CT4)
Combined Training 2 times per week (CT2)
The CT4 group will perform four sessions per week of combined exercise program. This intervention will last 12 weeks.
The CT2 group will perform two sessions per week of combined exercise program. This intervention will last 12 weeks.